Heraeus healthcare and medical technology portfolio expands
The Heraeus Group has announced its acquisition of Mo-Sci Corporation and spin off company ETS Technology Holdings. Both companies are located in Rolla, Missouri.
Mo-Sci was founded by Dr. Delbert Day in 1985 to develop and supply specialty glass and ceramic products for specific market applications.
It is now a leading supplier to the medical device industry with glass microspheres, fibres and powders. It also provides sealing glass and test services for the aerospace, automotive, and electronics industries.
The company was led by Ted Day, Delbert’s son, up until his death in September 2020.
ETS was founded in 2012 to develop and commercialise a novel borate-based bioactive glass technology platform for wound care and hemostasis.
ETS received FDA clearance for its first product, Mirragen, a resorbable synthetic skin substitute, and continues to expand the technology to new applications.
The addition of these two new businesses will strengthen the Heraeus healthcare and medical technology portfolio, which includes market leadership in the supply of medical components and devices, the PALACOS orthopaedic bone cement line, and other technologies and innovations for the healthcare and medical device industries.
Nicolas Guggenheim, Head of Business Area Medical Technologies, said, “Across every treatment area, medical technology is changing rapidly. The acquisition of Mo-Sci and ETS gives us new capabilities to help our customers deliver innovative technologies and breakthrough treatments that will improve outcomes and patient care.”
Heraeus plans to keep the existing Mo-Sci team and facilities in Rolla.
Image: Mo-Sci in Rolla, Missouri